Skip to content

Effect of Products on skin ageing

To evaluate the invivo efficacy and safety of a skin care formulation in terms of reduction in wrinkles and fine lines, density of dark spots, improvement in skin smoothness, plumpness, skin even tone, skin moisturization, trans epidermal water loss, skin brightening, skin firmness and skin elasticity on healthy female subjects. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073443
Enrollment
36
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: K ELA FACE OIL: Product is applied on whole face once at night for period of 28 days Control Intervention1: Nil: NA

Sponsors

Kama Ayurveda Pvt Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy subjects 2. Skin is healthy on the studied anatomic 3. Having Crows feet wrinkle 4. Having at least 1 dark spot (age spot). 5. Having varied skin type & sensitive skin type

Exclusion criteria

Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2. Having refused to give his/her assent by not signing the consent form 3. Taking part in another study liable to interfere with this study 4. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less 5. than 6 months) 6. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 7. months) 8. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic 9. products or food products. 10. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes(the only medication permitted is paracetamol). 11. Having cutaneous hypersensitivity. 12. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in wrinkles & fine lines, density of dark spots, improvement in skin smoothness, plumpness, skin even tone, skin moisturization, trans epidermal water loss, skin brightening, skin firmness & skin elasticityTimepoint: Baseline, Day 14, Day 28

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026